Clinical Trial
Safety, Feasibility, and Efficacy of Transcutaneous Spinal Cord Stimulation on Stabilizing Blood Pressure for Acute Inpatients With Spinal Cord Injury
ClinicalTrials.gov1/1/2022·01/01/22🌐 USA
Summary
This study assesses the safety, feasibility, and efficacy of transcutaneous spinal cord stimulation delivered via the Onward ARC-EX system for stabilizing blood pressure in acute inpatients with spinal cord injury. The non-invasive stimulation targets sympathetic circuits to restore autonomic cardiovascular control during the acute recovery phase.
Why it matters
The ARC-EX system represents a major advancement in non-invasive spinal cord stimulation technology. If proven effective, this external stimulation approach could make neuromodulation therapy accessible to a broad SCI population without requiring surgery.
#Phase 2#Spinal Cord Injury#Neurostimulation#Spinal Cord Stimulation#Non-invasive#Neuroprosthetics#USA
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in